ArticleFrontiers in cardiovascular medicine2026
Prevalence of right bundle branch block and its impact on recurrence after ablation in patients with atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of right bundle branch block (RBBB) among patients with atrial fibrillation (AF) and its prognostic value after radiofrequency catheter ablation (RFCA) remain unclear. This study aimed to investigate the prevalence of complete RBBB (CRBBB) and incomplete RBBB (IRBBB) and to evaluate their impact on recurrence after RFCA in patients with AF. Methods: A total of 949 consecutive AF patients who underwent Results: The prevalence of CRBBB and IRBBB among AF patients was 5.3% ( Conclusion: The prevalence of RBBB is relatively high among AF patients undergoing RFCA and increases with aging. CRBBB may be an independent predictor of recurrence, whereas IRBBB is not associated with recurrence. The results should be proved by prospective multicenter investigation in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.